LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing concerns they will ...

Choosing the right degree is one of the most important decisions for students interested in healthcare. Two popular options are Pharmacy and Biotechnology. Both are connected to medicine and health, ...

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded fund launched ...

The interest and need are here. The authors acknowledge that cloud-based and AI-driven technologies are increasingly automating drug discovery and advancing biomedical research. The global AI market ...

Imagine lab coats, petri dishes, and beakers with bubbling liquids. That’s what many think of biotechnology. But today’s biotech is more like Tony Stark’s lab and Olympic training facilities. It has ...

Trinity Biotech launched CGM+, an AI-native wearable biosensor for glucose and multi-data monitoring, targeting the expanding healthcare market. Trinity Biotech plc, a biotechnology company ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Data collected for venture ...

With the U.S. undergoing a crisis in its healthcare system, from racial disparities to high costs, biotechnology has emerged as an area of opportunity. With the help of artificial intelligence (AI), ...

Healthcare and biotech stocks have had a rough run since the giddy heights of the Covid pandemic. But now could be the perfect time to consider investing in these beaten-down but high-growth sectors.

The ASX biotech sector lost about 7% of its value in May. But not every stock lagged and hopes for a rebound abound.